Literature DB >> 18222170

Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling.

Natsuko Tanimura1, Shinichiroh Saitoh, Fumi Matsumoto, Sachiko Akashi-Takamura, Kensuke Miyake.   

Abstract

Toll-like receptor 4 (TLR4) activates two distinct signaling pathways inducing production of proinflammatory cytokines or type I interferons (IFNs), respectively. MyD88 and TIRAP/Mal are essential adaptor molecules for the former but not for the latter pathway. In contrast, TRIF/TICAM-1 and TRAM/TICAM-2 are essential for both. TIRAP is a sorting adaptor molecule recruiting MyD88 to activated TLR4 in the plasma membrane. TRAM is thought to bridge between TLR4 and TRIF by physical association. Little is known, however, how TRAM interacts with TLR4 or with TRIF during LPS response. Here, we show that TRAM recruits TRIF to the plasma membrane. Moreover, LPS induces upregulation of TLR4-association with TRAM and their subsequent translocation into endosome/lysosome. The internalized signaling complex consisting of TLR4 and TRAM colocalizes with TRAF3, a signaling molecule downstream of TRIF, in endosome/lysosome. These results suggest that TLR4 activates TRIF-signaling in endosome/lysosome after relocation from the cell surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222170     DOI: 10.1016/j.bbrc.2008.01.061

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  95 in total

Review 1.  Emerging principles governing signal transduction by pattern-recognition receptors.

Authors:  Jonathan C Kagan; Gregory M Barton
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-11-13       Impact factor: 10.005

2.  CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.

Authors:  Ivan Zanoni; Renato Ostuni; Lorri R Marek; Simona Barresi; Roman Barbalat; Gregory M Barton; Francesca Granucci; Jonathan C Kagan
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

Review 3.  The specialized roles of immature and mature dendritic cells in antigen cross-presentation.

Authors:  Richard A Hopkins; John E Connolly
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 4.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 5.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

6.  High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.

Authors:  Masashi Suzuki; David K Pritchard; Lev Becker; Andrew N Hoofnagle; Natsuko Tanimura; Theo K Bammler; Richard P Beyer; Roger Bumgarner; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; Kensuke Miyake; John F Oram; Jay W Heinecke
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 7.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

Review 8.  The roles of TLRs, RLRs and NLRs in pathogen recognition.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Int Immunol       Date:  2009-02-26       Impact factor: 4.823

9.  IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance.

Authors:  Yanbao Xiong; Meghan Pennini; Stefanie N Vogel; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2013-05-21       Impact factor: 4.962

10.  Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.

Authors:  Xue Yang; Liping Ou; Min Tang; Yin Wang; Xiaorong Wang; E Chen; Jianjun Diao; Xiaohou Wu; Chunli Luo
Journal:  Tumour Biol       Date:  2015-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.